| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |